MSH6 and prostate cancer: Cancer incidence in the MSH6 mutation positive families includes, in order of frequency (in how many families the cancer was observed): CRC in 23 families (79%); cancer of the endometrium in 17 families (59%); breast or prostate cancer in 7 families (24%); and ovarian cancer in 5 families (17%).